Literature DB >> 11836434

Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions.

Isabelle Widmer1, Marion Wernli, Felix Bachmann, Fred Gudat, Gieri Cathomas, Peter Erb.   

Abstract

Expression of human herpesvirus 8 viral Bcl-2 protein was demonstrated in spindle cells of late-stage Kaposi's sarcoma lesions but not in primary effusion lymphoma cell lines. In contrast, strong expression of human Bcl-2 was found in stimulated primary effusion lymphoma cells, whereas in Kaposi's sarcoma lesions preferential mononuclear cells, and to a lesser extent spindle cells, stained positive.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836434      PMCID: PMC135929          DOI: 10.1128/jvi.76.5.2551-2556.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays.

Authors:  R G Jenner; M M Albà; C Boshoff; P Kellam
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.

Authors:  D S Bellows; B N Chau; P Lee; Y Lazebnik; W H Burns; J M Hardwick
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation.

Authors:  F Bachmann; S A Buechner; M Wernli; S Strebel; P Erb
Journal:  J Invest Dermatol       Date:  2001-07       Impact factor: 8.551

4.  Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  C Parravicini; B Chandran; M Corbellino; E Berti; M Paulli; P S Moore; Y Chang
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 5.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.

Authors:  T F Schulz
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

6.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

7.  Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma.

Authors:  C B Morris; R Gendelman; A J Marrogi; M Lu; J M Lockyer; W Alperin-Lea; B Ensoli
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.

Authors:  R Sun; S F Lin; K Staskus; L Gradoville; E Grogan; A Haase; G Miller
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

10.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

View more
  11 in total

Review 1.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

Review 2.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

3.  Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation.

Authors:  Anastasia Gelgor; Inna Kalt; Shir Bergson; Kevin F Brulois; Jae U Jung; Ronit Sarid
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 4.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

5.  Biphasic modulation of apoptotic pathways in Cryptosporidium parvum-infected human intestinal epithelial cells.

Authors:  Jin Liu; Mingqi Deng; Cheryl A Lancto; Mitchell S Abrahamsen; Mark S Rutherford; Shinichiro Enomoto
Journal:  Infect Immun       Date:  2008-12-15       Impact factor: 3.441

Review 6.  [Humanes herpesvirus 8 (HHV-8) and Kaposi sarcoma].

Authors:  C Lebbé
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

7.  LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

Authors:  E Long; M Ilie; V Hofman; K Havet; E Selva; C Butori; J P Lacour; A M Nelson; G Cathomas; P Hofman
Journal:  Virchows Arch       Date:  2009-05-30       Impact factor: 4.064

8.  GLTSCR2/PICT-1, a putative tumor suppressor gene product, induces the nucleolar targeting of the Kaposi's sarcoma-associated herpesvirus KS-Bcl-2 protein.

Authors:  Inna Kalt; Tatyana Borodianskiy-Shteinberg; Adi Schachor; Ronit Sarid
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

9.  Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Christine M Burrer; Glenna W Foight; Amy E Keating; Gary C Chan
Journal:  Virus Res       Date:  2015-10-09       Impact factor: 3.303

Review 10.  Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?

Authors:  Patrick S Moore; Yuan Chang
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.